Meeting
2023 ASCO Annual Meeting
The SPEARHEAD-1 trial of afamitresgene autoleucel (afami-cel [formerly ADP-A2M4]): Analysis of overall survival in advanced synovial sarcoma.
Authors
Brian Andrew Van Tine
Washington University School of Medicine, St. Louis, MO
Brian Andrew Van Tine , Kristen N. Ganjoo , Jean-Yves Blay , Claudia Valverde , Dejka M. Araujo , Albiruni Ryan Abdul Razak , Axel Le Cesne , Scott Schuetze , Michael J Wagner , Steven Attia , Edouard Forcade , Mihaela Druta , Seth Pollack , Jane Bai , Paige Bayer , Erin Van Winkle , Elliot Norry , Cheryl McAlpine , Dennis Williams , Sandra P. D'Angelo
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Sarcoma
Track
Sarcoma
Sub Track
Soft Tissue Tumors
Clinical Trial Registration Number
NCT04044768
Citation
J Clin Oncol 41, 2023 (suppl 16; abstr 11563)
DOI
10.1200/JCO.2023.41.16_suppl.11563
Abstract #
11563
Poster Bd #
497
Abstract Disclosures
Similar Posters
Poster
2020 ASCO Virtual Scientific Program
SPEARHEAD-1: A phase II trial of ADP-A2M4 SPEAR T cells in patients with advanced synovial sarcoma or myxoid/round cell liposarcoma.
First Author: Dejka M. Araujo
Poster
2024 ASCO Annual Meeting
Phase IIA study of high-affinity TCR-T (TAEST16001) targeting NY-ESO-1 in soft tissue sarcoma.
First Author: Jiayong Liu
Poster
2023 ASCO Gastrointestinal Cancers Symposium
Phase I study of autologous transgenic T cells expressing high affinity mesothelin-specific T-cell receptor (TCR; FH-TCR TMSLN) in patients with metastatic pancreatic ductal adenocarcinoma (mPDA).
First Author: E. Gabriela Chiorean
Poster
2023 ASCO Gastrointestinal Cancers Symposium
A phase I study of GPC3 targeted CAR-T cell therapy in advanced GPC3-expressing hepatocellular carcinoma (HCC).
First Author: Changqing Xie